Intestinal organoids as models for the development of antivirals against human norovirus and rotavirus.
The role of intestinal microbiota in the development of inflammatory bowel diseases: identification of potential beneficial and harmful microbiota through ex vivo organoid technology.
The role of intestinal microbiota in the development of inflammatory bowel diseases: identification of potentially beneficial and harmful micorbiota through ex vivo organoid technology.
REGENERATIVE MEDICINE FOR INTESTINAL FAILURE: DEMONSTRATING THE POTENTIAL FOR INTESTINAL ORGANOIDS TO REPOPULATE THE EPITHELIUM OF THE INTESTINE
INTESTINAL ORGANOIDS DERIVED FROM INFLAMMATORY BOWEL DISEASE PATIENTS SHOW UNALTERED TRANSCRIPTIONAL PROFILES WHEN COMPARED TO HEALTHY CONTROL ORGANOIDS
Fluorescence intensity and Fluorescence Lifetime Imaging Microscopies (FLIM) of cell differentiation in the small intestinal organoids using cholera toxin